August 17, 2020Annals of Internal Medicine
Three-Year Outcomes of Bariatric Surgery in Patients With Obesity and Hypertension
Why the study?
The midterm effects of bariatric surgery on blood pressure in patients with obesity and hypertension remained uncertain.
Does Roux-en-Y gastric bypass (RYGB) plus medical therapy improve blood pressure control and reduce medication use in patients with obesity and hypertension?
Population
Patients with obesity and hypertension
Comparison
RYGB plus MT vs MT alone
Design
Single-center nonblinded randomized clinical trial
Follow-up
3 years
Authors
Discussion
Loading...
Member takes
Implication
Supports offering RYGB to obese patients with hypertension for better control with fewer drugs; extends RCT evidence to midterm outcomes.
Structured PICO
Does Roux-en-Y gastric bypass (RYGB) plus medical therapy improve blood pressure control and reduce medication use in patients with obesity and hypertension?
P
Population
Patients with obesity and hypertension
I
Intervention
Roux-en-Y gastric bypass (RYGB) plus medical therapy (MT)
C
Comparator
Medical therapy (MT) alone
O
Outcome
At least a 30% reduction in total number of antihypertensive medications while maintaining BP less than 140/90 mm Hgsurrogate
Roux-en-Y gastric bypass is an effective strategy for midterm blood pressure control and hypertension remission, requiring fewer medications in patients with obesity and hypertension.
Limitations
- Single-center
- nonblinded trial
Cite This Study
Schiavon et al. (2020) studied this question.